Synthelabo's device sales up 11% in first half:
This article was originally published in Clinica
Synthelabo's medical device sales rose 11.4% to Fr 389 million ($76 million) in the first six months of 1996 compared with the previous year. Ela Medical achieved sales of Fr 288 million, an increase of 12.8% over the first half of 1995. Sales at Porges, Synthelabo's catheter division, were Fr 101 million, an increase of 7.4% on a comparable basis. Synthelabo group sales rose 10.9% in the first half of 1996 to Fr 5,122.6 million and the company says 1996 year sales should top Fr 10,000 million.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.